Navigation Links
MedImmune's Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
Date:8/23/2007

Native American infants, with an overall incidence and severity of adverse events (AEs) that were similar between the motavizumab and the placebo groups. The mortality rates were not statistically different between groups (0.4 percent in the placebo arm, n=2 and 0.3 percent in the motavizumab arm, n=3) and were not considered to be related to the study drug. As was suggested in the pivotal Phase 3 trial conducted in high-risk, preterm infants, rates of hypersensitivity related skin rashes within two days of dosing were seen in about one percent of treated children in the motavizumab group.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Food and Drug Administration (FDA) approval for an infectious disease. With the development of motavizumab, MedImmune continues to reinforce its commitment to developing anti-RSV products. In a head-to-head comparative Phase 3 trial with Synagis, motavizumab met its primary endpoint of reducing RSV-related hospitalizations in high-risk pediatric patients and met its secondary endpoint of reducing medically attended, outpatient respiratory tract infections in that patient group. MedImmune is also developing a small-molecule product candidate to prevent RSV as well as a vaccine against RSV, both of which are in Phase 1 clinical trials.

About RSV

Each year, up to 125,000 infants in the U.S. are hospitalized with severe RSV infections, the leading cause of lower respiratory tract infections
'/>"/>

SOURCE MedImmune, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
2. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
3. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
4. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
5. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
6. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
7. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
8. Pivotal Phase III Trial Showed Promacta (eltrombopag olamine) Raised Platelet Counts and Reduced Bleeding in Patients With Chronic ITP
9. Preclinical Study Finds Protease Inhibitor-Resistant HIV May Have Reduced Potential to Develop Resistance to Panacos Bevirimat
10. New Analysis of Data Shows Treatment With Abbotts Humira (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohns Disease
11. Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... SANTA CLARA, Calif. , Feb. 27, 2015  Finesse ... Finesse Solutions announced the expansion of ... The opening is planned for mid-March and access for ... access from the A-563, and located adjacent to the ... occupied by the Finesse automation engineering team and allow Finesse ...
(Date:2/26/2015)... , February 27, 2015 ... H2 2014 market research report to its store. ... Corneal Ulcers, therapeutic pipeline. The report ... on the therapeutic development for Corneal Ulcers. Corneal ... that includes bacterial infections, viral infections & fungal ...
(Date:2/26/2015)... , Feb. 26, 2015  Tandem Diabetes Care®, ... company and manufacturer of the t:slim® and t:flex™ Insulin ... offering of 5,250,000 shares of its common stock at ... The net proceeds to Tandem from this offering are ... and commissions and other estimated offering expenses payable by ...
Breaking Medicine Technology:New Finesse Office in United Kingdom 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Pricing of Underwritten Public Offering of Common Stock 3
... ROSWELL, Ga., Sept. 1, 2011 Kimberly-Clark Health ... a double-digit price increase on synthetic exam gloves ... of raw materials, particularly butadiene and acrylonitrile.   ... for these raw materials along with inflationary pressures ...
... month, Floridians are recognizing "Plasma Protein Therapies Month," by ... throughout the "Sunshine State" and for the rare, genetic ... through plasma donation. Plasma protein therapies, which ... biotechnology product), are used every day to treat people ...
Cached Medicine Technology:Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 2Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 3
(Date:2/27/2015)... One of the biggest mistakes patients ... These tips help ensure you receive the most ... “Investing time and effort in your recovery and aftercare ... plastic surgeon,” says Dr. Kevin Sadati. , Studies have ... and longest lasting results following a facelift with utilizing ...
(Date:2/26/2015)... Guide to FDA Medical Device Regulations — ... a manufacturers needs to convince the FDA to accept ... implement UDI across a family of high-risk implantable devices, ... up-to-date, latest FDA regulations available. , ... is an FDAnews best-seller. , The 2015 Guide includes ...
(Date:2/26/2015)... February 26, 2015 Healthpointe is ... medical examiner, Dr. Neil Thomas Katz, MD, is ... practice locations throughout Southern California, including Long ... is board-certified and fellowship-trained to provide quality care, ... , Dr. Neil Katz provides surgical and non-surgical ...
(Date:2/26/2015)... 26, 2015 As the great passage ... for deeper meaning, more substantial roles and connections that ... do I live a life that still matters? As ... Younger Next Year Total Immersion Retreat , answers ... boasts unbelievable results and jump-starts a healthier life. A ...
(Date:2/26/2015)... Imagine a day without access to clean, ... and there was no one to help. For more than ... In 2015, more than 2.5 billion people will also lack ... A new initiative led by Nevada’s Desert Research Institute ... specifically on women – who often bear the brunt of ...
Breaking Medicine News(10 mins):Health News:Gallery of Cosmetic Surgery Announces Tips for Protecting Your Plastic Surgery Investment 2Health News:FDAnews Bestseller Updated: Guide to FDA Medical Device Regulations — 2015 Edition 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 2Health News:Southern California Medical Group is Now Offering Orthopedic Care for Cartilage Injuries and Degeneration 3Health News:The Aspen Club on Actively Aging: Telling a New Story on Aging 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 2Health News:DRI launches Global Initiative to Provide Women in Developing Countries with Clean Water 3
... A new study of metastatic breast cancer shows that ... their blood directly correlates with the length of their ... Brussels, Belgium, the results have the potential to improve ... Circulating tumor cells --cancer cells found in a patient,s ...
... VALLEY, PA (May 6, 2010) -- Olympus, a precision ... and surgical products, today announced the launch of the ... the only reprocessor on the market designed by an ... can simultaneously clean and disinfect two flexible endoscopes in ...
... ... an employee responds falsely to a confirmation request. While paper confirmations make it difficult ... boards supporting the use of secure electronic confirmations now give companies a better way to ... ...
... , ... researchers who are interested in achieving top performance from GPUs in diverse applications using ... GPUs from the Numerical Algorithms Group (NAG). , ... (Vocus) May 6, 2010 -- Developers and researchers who ...
... Urns.com Offers New Biodegradable ... And More Give People The Option To Have More A Eco-Friendly Funeral. , ... Goleta, CA (PRWEB) May 6, 2010 –- When a loved ... one where those left behind need to consider not only the wishes of the deceased, but ...
... , THURSDAY, May 6 (HealthDay News) -- If you were ... type of kidney cancer, you can relax. A new study suggests ... no concrete evidence of a need to alter milk drinking in ... genetic epidemiology at the University of Bristol in England, said in ...
Cached Medicine News:Health News:Survival in metastatic breast cancer directly linked to circulating tumor cells 2Health News:Olympus develops world's fastest, most compatible endoscope reprocessor 2Health News:Brian Fox to Speak on Audit Confirmation Fraud at the 2010 IAPP Annual Forum and Expo 2Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 2Health News:More GPU Routines for Technical Research Now Available from Numerical Algorithms Group 3Health News:Urns.com Announces Urns As An Eco Friendly Burial Alternative 2Health News:Study Disputes Link Between Milk and Kidney Cancer 2